← Open Payments lookup

MILLICENT ANIMLEY: Open Payments

NPI 1760104913 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,792 in 164 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $3,792

Food & beverage: $3,708Education: $84
CompanyPaymentsAmount
ABBVIE INC.46$753
Janssen Biotech, Inc.21$622
Takeda Pharmaceuticals U.S.A., Inc.18$372
Madrigal Pharmaceuticals8$300
QOL Medical, LLC9$230
PFIZER INC.7$220
Salix Pharmaceuticals, a division of Bausch Health US, LLC8$197
Braintree Laboratories, Inc.3$150
Ipsen Biopharmaceuticals, Inc5$118
Lilly USA, LLC5$110

Products named: TREMFYA, RINVOQ, ENTYVIO, REZDIFFRA, Sucraid, XIFAXAN, VELSIPITY, VIBERZI.

Industry payments across DC — which companies pay providers there.